Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Vireo Growth Inc. (VREOF : OTC)

• Company Description    Vireo Growth Inc. operates as a cannabis company which cultivates, manufactures, processes and distributes medical and adult-use cannabis products principally in Maryland, Minnesota and New York. Vireo Growth Inc. is based in Minneapolis, Minnesota. Number of Employees: 520

• Price / Volume Information    Yesterday's Closing Price: $0.44 Daily Weekly Monthly 20 Day Moving Average: 384,002 shares Shares Outstanding: 339.75 (millions) Market Capitalization: $149.49 (millions) Beta: 52 Week High: $0.80 52 Week Low: $0.23 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -37.59% -38.69% 12 Week 11.96% 1.70% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 207 SOUTH 9TH STREET - MINNEAPOLIS,MN 55402 USA ph: 612-999-1606 fax: - investor@vireogrowth.com http://www.vireogrowth.com

• General Corporate Information    Officers John Mazarakis - Chief Executive Officer and Co-Executive Chairman Kyle E. Kingsley - Co-Executive Chairman Amber H. Shimpa - President Tyson Macdonald - Chief Financial Officer Ross M. Hussey - Director Peer Information Vireo Growth Inc. (BJCT) Vireo Growth Inc. (CADMQ) Vireo Growth Inc. (APNO) Vireo Growth Inc. (UPDC) Vireo Growth Inc. (IMTIQ) Vireo Growth Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 92767B105 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/12/25 Share - Related Items Shares Outstanding: 339.75 Most Recent Split Date: (:1) Beta: Market Capitalization: $149.49 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.01 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.56 Price/Cash Flow: - Price / Sales: 1.22 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 91.43% vs. Previous Quarter: 95.85% ROE 06/30/25 - -39.54 03/31/25 - -145.36 12/31/24 - - ROA 06/30/25 - -10.20 03/31/25 - -11.15 12/31/24 - -13.02 Current Ratio 06/30/25 - 1.28 03/31/25 - 1.66 12/31/24 - 1.70 Quick Ratio 06/30/25 - 1.03 03/31/25 - 1.49 12/31/24 - 1.54 Operating Margin 06/30/25 - -29.27 03/31/25 - -26.37 12/31/24 - -28.10 Net Margin 06/30/25 - -34.13 03/31/25 - -27.71 12/31/24 - -28.20 Pre-Tax Margin 06/30/25 - -23.47 03/31/25 - -18.99 12/31/24 - -17.00 Book Value 06/30/25 - 0.79 03/31/25 - 0.15 12/31/24 - 0.16 Inventory Turnover 06/30/25 - 2.03 03/31/25 - 2.30 12/31/24 - 2.40 Debt-to-Equity 06/30/25 - 0.34 03/31/25 - 1.44 12/31/24 - 1.28 Debt-to-Capital 06/30/25 - 25.53 03/31/25 - 58.97 12/31/24 - 56.20

Powered by Zacks Investment Research ©